Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986
SortApplication
TherapeuticPeer-ReviewedPubMedJournal of radiation research · 2026

Endoscopic ultrasound-guided fiducial marker placement for image-guided proton beam therapy in pancreatic cancer: implications for positional accuracy and position management.

Takeuchi K, Ishikawa T, Yamao K, Mizutani Y et al.

High geometric precision is essential in proton beam therapy (PBT) for pancreatic cancer. This study evaluated inter-fraction positional accuracy during image-guided PBT using radiopaque surrogates an…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedRadiation oncology (London, England) · 2026

Metal artifact reduction for 3 T MRI-only prostate radiotherapy in patients with hip prostheses: impact on target definition, synthetic CT generation, dose calculation, and fiducial marker identification.

Coskun M, Petersson JS, Wetterstedt SA, Brynolfsson P et al.

Magnetic resonance imaging (MRI) offers superior soft-tissue contrast and MRI-only radiotherapy (RT) eliminates uncertainties associated with computed tomography (CT)-to-MRI image registration. An MRI…

Diagnostic📖 Free full textPeer-ReviewedPubMedRadiographics : a review publication of the Radiological Society of North America, Inc · 2026

Selection of Breast Biopsy Markers: Effect on Breast Imaging Procedures, Follow-up, and Costs.

Moseley TW, Adrada BE, Arribas EM, Urban MW et al.

Breast biopsy markers have evolved from simple metallic markers to sophisticated multimaterial devices that serve critical purposes throughout the breast cancer care continuum. This evolution began at…

Therapeutic📖 Free full textPeer-ReviewedPubMedBiomedicines · 2026

Feasibility of Conventional Abdominal Ultrasound for Monitoring Tumor Size After Stereotactic Body Radiotherapy for Hepatocellular Carcinoma.

Ueno M, Yamanouchi Y, Hanazawa H, Takabatake H et al.

Background/Objectives : Stereotactic body radiotherapy (SBRT) is increasingly used for hepatocellular carcinoma (HCC) that is unsuitable for surgery, radiofrequency ablation (RFA), or transplantation.…

TherapeuticQA & dosimetry📖 Free full textPeer-ReviewedPubMedPhysics in medicine and biology · 2026

A real-time image-guided six-degree-of-freedom internal-external correlation framework for motion monitoring on a standard linear accelerator.

Kaczynska A, Jin F, Stewart M, Kipritidis J et al.

Objective.Real-time six-degree-of-freedom (6DoF) tumour motion monitoring is important for accurate stereotactic body radiotherapy (SBRT) of thoracic and abdominal cancer sites, yet existing approache…

QA & dosimetry📖 Free full textPeer-ReviewedPubMedJournal of applied clinical medical physics · 2026

Impact of MRI slice thickness and fiducial marker orientation on geometric accuracy in multi-echo GRE imaging for prostate radiotherapy planning.

Hayashi A, Takahashi Y, Sanuki N, Yamashita Y et al.

BackgroundPrecise target definition in prostate radiotherapy requires accurate computed tomography (CT)-magnetic resonance imaging (MRI) image registration using gold fiducial markers (GFMs). While mu…

QA & dosimetryPeer-ReviewedPubMedThe British journal of radiology · 2026

Dosimetric robustness of tumour- and fiducial-based tracking in Radixact lung stereotactic body radiotherapy: a four-dimensional CT-based simulation using imaging-derived tracking-error scenarios.

Ebinuma Y, Inoue T, Shirata R, Takatsu J et al.

ObjectivesTo compare the dosimetry and robustness of two Radixact Synchrony lung stereotactic body radiotherapy (SBRT) tracking strategies: tumour-based lung tracking with respiratory modelling (LwR) …

QA & dosimetry📖 Free full textPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Intra-respiratory variation in tumour-diaphragm geometric association as a potential surrogate for dynamic tumour-tracking radiotherapy.

Iwai T, Yoneyama M, Kishi N, Adachi T et al.

Background and Purpose: For thoracic and upper abdominal tumours, respiratory motion management is essential; dynamic tumour-tracking radiotherapy (DTT-RT) is one such approach, but it typically requi…

TherapeuticQA & dosimetryPeer-ReviewedPubMedInternational journal of radiation oncology, biology, physics · 2026

Liver tumor motion and reconstructed doses in a clinical trial of respiratory gated proton therapy for hepatocellular carcinoma.

Nankali S, Worm ES, Thomsen JB, Stick LB et al.

PurposePencil beam scanning proton therapy of hepatocellular carcinoma (HCC) may reduce the risk of radiation-induced liver disease compared to photon radiotherapy, but tumor motion and anatomical cha…

Therapeutic📖 Free full textPeer-ReviewedPubMedJournal of radiation research · 2026

Endovascular pulmonary arterial fiducial marker placement for particle radiotherapy using proton or carbon-ion beams for lung cancer.

Terashima K, Gentsu T, Takahashi D, Matsuo Y et al.

This study evaluated the safety, feasibility and efficacy of endovascular pulmonary arterial fiducial marker (EVFM) placement for image-guided particle therapy using proton or carbon-ion beams in pati…

Therapeutic📖 Free full textPeer-ReviewedPubMedJournal of applied clinical medical physics · 2026

Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical Trial.

Schaly B, Mendez LC, Khawaja M, Black A et al.

IntroductionThe multi-institutional HOPE trial (NCT04197141) compared conventional (25 fractions over 5 weeks) to ultra-hypofractionated (5 fractions over 1.5 weeks) whole pelvis radiotherapy for unfa…

Therapeutic📖 Free full textPeer-ReviewedPubMedBMJ open · 2026

The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1-3 prostate cancer.

Hayhurst W, Uribe-Lewis S, Uribe J, Mikropoulos C et al.

Introduction Long-term follow-up after low-dose rate brachytherapy and ultra-fractionated radiotherapy for localised prostate cancer has demonstrated impressive survival statistics with low toxicity p…

Therapeutic📖 Free full textPeer-ReviewedPubMedPhysics and imaging in radiation oncology · 2026

Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator.

Serpa M, Wiehle R, Rothe T, Küchler S et al.

Background and purpose Intrafraction motion degrades the efficacy of radiation therapy. We reported on the implementation of focal dose-escalated stereotactic body radiation therapy (HypoFocal-SBRT) f…

TherapeuticPeer-ReviewedPubMedJournal of bronchology & interventional pulmonology · 2026

Approaches for Lung Fiducial Markers Insertion in Stereotactic Body Radiotherapy: A Systematic Review and Meta-Analysis.

Abellan C, Mouraux S, Janett S, von Garnier C et al.

BackgroundPulmonary fiducial markers (FMs) allow real-time tracking for stereotactic body radiotherapy (SBRT) by CyberKnife, which is an alternative to surgery in early-stage inoperable non-small-cell…

Therapeutic📖 Free full textPeer-ReviewedPubMedInternational journal of particle therapy · 2026

Universal Fiducial Markers for Multi-Modal Radiotherapy.

Liu J, Bamberger C, Iqbal N, Reynolds K et al.

PurposeIntegrating multiple radiotherapy modalities, including photon and proton therapy, within a single clinical facility requires universal fiducial markers that perform reliably across all imaging…

TherapeuticPeer-ReviewedPubMedClinical & translational oncology · 2026

Impact of image-guided radiation therapy with intraprostatic seeds on long-term toxicity in prostate cancer patients undergoing risk-adapted intensification therapy.

Zapatero A, Castro P, Martin de Vidales C, Roch M et al.

ObjectivesTo evaluate how the implementation of intensity-modulated/image-guided RT (IMRT/IGRT) with intraprostatic seeds can impact the risk of late gastrointestinal (LGI) and genitourinary (LGU) tox…

Therapeutic📖 Free full textCited 1×Peer-ReviewedPubMedJournal of applied clinical medical physics · 2026

Application of intrahepatic fiducial markers in carbon ion radiotherapy for pancreatic cancer-Achieving higher precision treatment.

Nagata J, Kusano Y, Komori M, Takayama Y et al.

Background Carbon-ion radiotherapy (CIRT) delivers highly conformal tumor doses while sparing surrounding organs-at-risk (OAR). However, density variations along the beam path and interfractional targ…

Therapeutic📖 Free full textCited 1×Peer-ReviewedPubMedJournal of applied clinical medical physics · 2025

Impact of intrafraction fiducial tracking on planning target margins during prostate stereotactic body radiotherapy using Brainlab ExacTrac Dynamic with robotic couch correction.

Worth M, Brancato DC, Lo J, Kole TP.

BackgroundPlanning target volume (PTV) margin reduction has been demonstrated to result in decreased acute genitourinary and gastrointestinal toxicity in patients treated with definitive stereotactic …

Therapeutic📖 Free full textPeer-ReviewedPubMedJournal of radiation research · 2025

Dosimetric effect of internal error correction on pubic bones in image-guided passive scattering proton therapy for prostate cancer.

Takemasa K, Kato T, Sasaki S, Narita Y et al.

Image-guided passive scattering proton therapy (PSPT) has been widely adopted in Japan and worldwide, with substantial long-term clinical data supporting its efficacy in treating prostate cancer. Howe…

QA & dosimetry📖 Free full textCited 1×Peer-ReviewedPubMedJournal of applied clinical medical physics · 2025

Distance-based assessment of spatial artifact extension in the prostate from fiducial markers in diffusion-weighted magnetic resonance imaging.

Coskun M, Brynolfsson P, Gustafsson CJ, Gunnlaugsson A et al.

Background Fiducial markers in image-guided prostate cancer radiotherapy reduce geometric uncertainty during daily patient setup and enable assessment of target position changes. Diffusion-weighted ma…

TherapeuticPeer-ReviewedPubMedJournal of vascular and interventional radiology · 2025

Fiducial Marker Placement for Gated Radiotherapy Using Real-Time Tumor-Tracking in Pancreatic Cancer: A Comparative Analysis of Transarterial and Percutaneous Approaches.

Kato D, Abo D, Morita R, Katoh N et al.

PurposeTo assess and compare the feasibility and safety of transarterial and percutaneous fiducial marker placements for gated radiotherapy using real-time tumor-tracking (RTRT) in patients with pancr…

TherapeuticCited 1×Peer-ReviewedPubMedJournal of medical radiation sciences · 2024

Liver stereotactic body radiation therapy without fiducial or retained ethiodized oil guidance warrants greater than 5 mm planning target volumes.

Breazeale A, Rahmani R, Gallagher K, Nabavizadeh N.

IntroductionFor liver stereotactic body radiation therapy (SBRT), the placement of fiducial markers or retained ethiodized oil by transarterial chemoembolisation (TACE) provides a landmark for consist…

Therapeutic📖 Free full textCited 14×Peer-ReviewedPubMedClinical and translational radiation oncology · 2023

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Kita N, Tomita N, Takaoka T, Okazaki D et al.

Background and purpose The present study attempted to identify risk factors for symptomatic radiation pneumonitis (RP) after stereotactic body radiotherapy (SBRT) in patients with early-stage non-smal…

Therapeutic📖 Free full textCited 10×Peer-ReviewedPubMedThe British journal of radiology · 2023

Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.

Cloitre M, Valerio M, Mampuya A, Rakauskas A et al.

Objectives We conducted a phase I/II prospective trial to determine whether stereotactic dose escalation to the dominant intra-prostatic nodule (DIN) up to 50 Gy incorporating a rectal balloon spacer …

Therapeutic📖 Free full textCited 7×Peer-ReviewedPubMedPloS one · 2022

Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning.

Tascón-Vidarte JD, Stick LB, Josipovic M, Risum S et al.

We investigate the accuracy of intensity-based deformable image registration (DIR) for tumor localization in liver stereotactic body radiotherapy (SBRT). We included 4DCT scans to capture the breathin…

Therapeutic📖 Free full textCited 8×Peer-ReviewedPubMedJournal of medical radiation sciences · 2022

Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer.

Iizumi T, Ishikawa H, Sekino Y, Tanaka K et al.

Introduction To confirm the feasibility of hypofractionated proton beam therapy (PBT), we compared the acute adverse event rates and International Prostate Symptom Score (IPSS) in prostate cancer pati…

Therapeutic📖 Free full textCited 13×Peer-ReviewedPubMedJournal of applied clinical medical physics · 2021

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning.

Tsubouchi T, Hamatani N, Takashina M, Wakisaka Y et al.

Purpose Carbon ion radiotherapy for prostate cancer was performed using two fine needle Gold Anchor (GA) markers for patient position verification in Osaka Heavy Ion Medical Accelerator in Kansai (Osa…

Therapeutic📖 Free full textCited 13×Peer-ReviewedPubMedStrahlentherapie und Onkologie · 2020

Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.

Böckelmann F, Putz F, Kallis K, Lettmaier S et al.

Purpose To investigate the dosimetric influence of daily interfractional (inter) setup errors and intrafractional (intra) target motion on the planning target volume (PTV) and the possibility of an of…

QA & dosimetryTherapeutic📖 Free full textCited 20×Peer-ReviewedPubMedJournal of applied clinical medical physics · 2020

Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments.

Korpics MC, Rokni M, Degnan M, Aydogan B et al.

Background Fiducial markers are frequently used before treatment for image-guided patient setup in radiation therapy (RT), but can also be used during treatment for image-guided intrafraction motion d…

Therapeutic📖 Free full textCited 7×Peer-ReviewedPubMedEndoscopy international open · 2019

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types.

Rigter LS, Rijkmans EC, Inderson A, van den Ende RPJ et al.

Background and study aims To facilitate image guidance during radiotherapy of rectal cancer, we investigated the feasibility of fiducial marker placement. This study aimed to evaluate technical succes…

Therapeutic📖 Free full textCited 33×Peer-ReviewedPubMedRadiation oncology (London, England) · 2019

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking.

Scher N, Bollet M, Bouilhol G, Tannouri R et al.

Purpose The purpose of this study was to assess the feasibility, efficacy and toxicity of fiducial marker implantation and tracking in CyberKnife® stereotactic radiation therapy (SBRT) applied to extr…

Therapeutic📖 Free full textCited 21×Peer-ReviewedPubMedRadiation oncology (London, England) · 2018

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Nakajima K, Iwata H, Ogino H, Hattori Y et al.

Background Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung…

Therapeutic📖 Free full textCited 7×Peer-ReviewedPubMedRadiology case reports · 2017

The advantage of iron-containing fiducial markers placed with a thin needle for radiotherapy of liver cancer in terms of visualization on MRI: an initial experience of Gold Anchor.

Tanaka O, Nishigaki Y, Hayashi H, Iida T et al.

Radiotherapy for liver malignancy is increasing due to advances in radiotherapy technique. Visualization of the tumor as well as fiducial markers is essential. To see if improved visibility exists on …

Therapeutic📖 Free full textCited 19×Peer-ReviewedPubMedRadiation oncology (London, England) · 2017

Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.

Versteijne E, Gurney-Champion OJ, van der Horst A, Lens E et al.

Background The delineation of pancreatic tumors on CT is challenging. In this study, we quantified the interobserver variation for pancreatic tumor delineation on 3DCT as well as on 4DCT. Methods Eigh…

QA & dosimetry📖 Free full textCited 47×Peer-ReviewedPubMedRadiation oncology (London, England) · 2017

Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.

Shimohigashi Y, Toya R, Saito T, Ikeda O et al.

BackgroundFor stereotactic body radiation therapy (SBRT) of liver tumors, tumor motion induced by respiration must be taken into account in planning and treatment. We evaluated whether liver tumor mot…

QA & dosimetryCited 20×Peer-ReviewedPubMedActa oncologica (Stockholm, Sweden) · 2017

Cone beam CT-based set-up strategies with and without rotational correction for stereotactic body radiation therapy in the liver.

Bertholet J, Worm E, Høyer M, Poulsen P.

BackgroundAccurate patient positioning is crucial in stereotactic body radiation therapy (SBRT) due to a high dose regimen. Cone-beam computed tomography (CBCT) is often used for patient positioning b…

Showing the 60 most recent of 102 papers in this topic.Browse every paper →